At the MD Anderson Cancer Center in Houston, Texas, Dr Jean Pierre Issa has been pioneering the use of two epigenetic drug therapies - decitabine and azacitidine.
BBC: RELATED BBC SITES
应用推荐
模块上移
模块下移
不移动